Skip to content

The Volume of Blood Submitted for Culture in Neonates - a Multicentre Quality Improvement Initiative.

The Volume of Blood Submitted for Culture in Neonates - a Multicentre Initiative to Improve the Value of the Test by Bedside Weighing of Blood Samples.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04455022
Acronym
VOB4C
Enrollment
600
Registered
2020-07-02
Start date
2022-05-10
Completion date
2023-07-08
Last updated
2022-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Sepsis

Keywords

blood culture, newborn, blood volume, quality improvement, neonatal sepsis

Brief summary

The study will examine if introducing the practice of checking the volume of blood culture samples in neonates by bedside weighing will improve the sensitivity of the test and increase confidence in negative results affecting the rate of extended antibiotic treatment in neonates with negative blood cultures.

Detailed description

In the first part of the study (pre-intervention) the actual volumes of blood submitted for culture in neonates from participating neonatal units will be examined for the period of six months. The culture vials will be pre-weighted using precision scale before delivery to the units. After collecting the sample the vials will be weighted again at the time of admission to microbiology laboratory. At the end of the first phase, the results will be revealed to clinical teams and discussed. The sample volume control by using bedside precision scale will be introduced to the participating units along with educational actions to raise the awareness of importance of collecting adequate volume of blood for culture. The minimum volume of blood will be defined as at minimum 1 ml. The paramount role of blood culture in process of ruling out newborn sepsis will be emphasized. In the second phase of the study clinicians in participating centres will have an opportunity of measuring the volume of samples just after collecting. The volumes will also be independently controlled in the microbiology laboratory. The second phase will also last six months. Collected volumes will be compared to results from pre-intervention period. Clinical outcome measured by frequency of antibiotic treatment in newborn patients with negative blood culture will be compared before and after implemented changes. We hypothesize that introducing routine bedside control of the blood volume submitted for culture will result in increase confidence in negative blood culture results and decrease of antibiotic use in newborn population.

Interventions

OTHERBedside blood culture bottles weighing combined with educational interventions.

Educational actions will be taken to raise the awareness of importance of collecting adequate volume of blood for culture (posters, leaflets and educational activities). The minimum volume will be defined as at least 1 ml. The paramount role of blood culture in process of ruling out newborn sepsis will be emphasized. The sample volume control by using bedside precision scale will be introduced.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Months
Healthy volunteers
No

Inclusion criteria

\- Any infant in a neonatal ward who has a blood culture collected (either early-onset or late-onset sepsis suspected).

Exclusion criteria

\- There is no

Design outcomes

Primary

MeasureTime frameDescription
The volume of blood submitted for culture.Through study completion, an average of 1 year.The volume of blood submitted for culture will be determined by weighing blood culture bottle before and after blood inoculation. The percentage of adequately filled blood culture bottles, i.e. at least 1 ml, will be compared between each study period.

Secondary

MeasureTime frameDescription
The use of systemic antibiotics.Through study completion, an average of 1 year.The use of antibiotic therapy \>72 hours despite negative blood culture results. The percentage of patients treated with antibiotics \>72 hours despite negative blood cultures will be compared between each study period.
Blood culture false-positive rate (contamination rate).Through study completion, an average of 1 year.The rate of blood culture contamination will be calculated by dividing the number of contaminated blood cultures by the total number of blood cultures collected during the study period.
Blood culture true-positive rate.Through study completion, an average of 1 year.The rate of true positive blood cultures will be calculated by dividing the number of blood cultures that yield a pathogenic microorganism by the total number of blood cultures collected during the study period.

Countries

Poland

Contacts

Primary ContactJustyna Romańska, MD
justyna_romanska@gazeta.pl225830340
Backup ContactTomasz Wawrzoniak, MD
wawrzon@mp.pl225830336

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026